Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-001937
Filing Date
2017-03-02
Accepted
2017-03-02 15:04:36
Documents
1
Period of Report
2017-02-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4020917friedman_oramed.html 4  
1 OWNERSHIP DOCUMENT f4020917friedman_oramed.xml 4 3774
  Complete submission text file 0001213900-17-001937.txt   5374
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address HADASSA 6 TEL AVIV L3 6451306
Business Address
Friedman Aviad (Reporting) CIK: 0001683729 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 17658303